Stock MSCL SATELLOS BIOSCIENCE INC.
Add to a list
To use this feature you must be a member
Log inSign up

Sector Chart Satellos Bioscience Inc.

Equities

MSCL

CA80401L3083

Market Closed - Toronto S.E.
Other stock markets
 03:59:59 2024-07-15 pm EDT 		5-day change 1st Jan Change
0.48 CAD -4.00% Intraday chart for Satellos Bioscience Inc. -4.00% +11.63%
Jul. 11 Satellos Bioscience Submits Regulatory Filing for Phase 1 Clinical Trial With SAT-3247 MT
Jul. 11 Satellos Bioscience Inc. Brief: Announcing Submission of Regulatory Filing to Commence a Phase 1 Clinical Trial with SAT-3247 MT
"Total Return" performance includes dividend payments over the period, as if they were reinvested at 100%.
End-of-day quotes

Sector Bio Therapeutic Drugs

Capi. Sales growth Profitability Finances EV / Sales P/E ratio
SATELLOS BIOSCIENCE INC. Stock Satellos Bioscience Inc.
 41.43M - - - - -
VERTEX PHARMACEUTICALS INCORPORATED Stock Vertex Pharmaceuticals Incorporated
 126B
ARGENX SE Stock argenx SE
 27.95B -
BIONTECH SE Stock BioNTech SE
 20.5B -
GENMAB A/S Stock Genmab A/S
 17.12B
BEIGENE, LTD. Stock BeiGene, Ltd.
 16.1B -
  1. Stock Market
  2. Equities
  3. MSCL Stock
  4. Charts Satellos Bioscience Inc.
  5. Sector Chart